Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: FDA takes unprecedented step toward more efficient global pharmaceutical manufacturing inspections https://t.co/8UccYmh8ll
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: FDA warns against using SARMs in body-building products https://t.co/IutC863qqs
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RonPiervincenzi: The @USPharmacopeia is in progress to use our expertise to set standards on opioid packaging and labeling, in partn… QT @SGottliebFDA: My statement on new #FDA strategies for addressing crisis of opioid addiction through innovation in drug packaging https://t.co/P4lq4zoRyZ)
SteveFDA (R-D.C.)
@SGottliebFDA
More than 150,000 people in the U.S. die each year from cardiovascular disease caused by smoking combustible cigare… https://t.co/exitiJbSoH
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA works with device companies to thwart cybersecurity threats https://t.co/3OciB4Nqbz
SteveFDA (R-D.C.)
@SGottliebFDA
.@US_FDA to Recognize eight European Regulatory agencies to Conduct GMP Inspections in Mutual Recognition Agreement https://t.co/UCek2KpySH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RAPSorg: .@US_FDA to Recognize 8 EU Regulators to Conduct GMP Inspections in Mutual Recognition Deal | #Regulatory Focus https://t.co/9bUCMAwWjD
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: FDA works with device companies to thwart cybersecurity threats https://t.co/M8F1LKZ3xk
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_MCMi: Also see @FDAcdrhIndustry fact sheet - myths and facts about FDA's role in #medicaldevice cybersecurity (PDF):… QT @US_FDA: FDA works with device companies to thwart cybersecurity threats https://t.co/M8F1LKZ3xk)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: .@US_FDA to Recognize eight European Regulatory agencies to Conduct GMP Inspections in Mutual Recognition Agreement https://t.co/UCek2KpySH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @DepSecHargan: The best way to #FightFlu is by getting a flu shot. Learn more at https://t.co/ShzDClAFb5 https://t.co/WXryf9rAgm
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer https://t.co/UelksZNVPf
SteveFDA (R-D.C.)
@SGottliebFDA
RT @CDCgov: #Measles, mumps, and rubella are potentially serious diseases. Here’s the best protection. https://t.co/z09GhtIL6a
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA took enforcement action today against unproven products derived from marijuana that claim to treat/cure cancer https://t.co/cDmyTMhkzI
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA took enforcement action today against unproven products derived from marijuana that claim to treat/cure cancer https://t.co/cDmyTMhkzI
SteveFDA (R-D.C.)
@SGottliebFDA
FDA releases updated guidance for generic drug makers to give industry clarity and direction on application process https://t.co/80ahgbJjQ8
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: FDA is widening the scope of a new tool to facilitate pre-approval access to drugs https://t.co/dYoXA33gfe https://t.co/Qg8w9QID3n
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_MCMi: FDA will recognize inspections of mfg facilities by regulatory authorities in Austria, Croatia, France, Italy, Malt… QT @EMA_News: EU-@US_FDA mutual recognition of inspections of #medicines manufacturers enters operational phase https://t.co/zavojoKYF3)
SteveFDA (R-D.C.)
@SGottliebFDA
FDA is widening the scope of a new tool to facilitate pre-approval access to drugs https://t.co/uTfwL8EVXx
SteveFDA (R-D.C.)
@SGottliebFDA
Learn w/ @FDAOncology experts about #cancer #drugdevelopment. Apply to Oncology Center of Excellence Fellows Program https://t.co/2PwfOAfgKt